Calithera Biosciences Inc reports results for the quarter ended in December - Earnings Summary

Calithera Biosciences

01/04/2022 14:50

* Calithera Biosciences Inc  CALA.OQ  reported a quarterly
adjusted loss of 92 cents​​ per share for the quarter ended in
December. The mean expectation of five analysts for the quarter
was for a loss of 24 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * The mean earnings estimate of analysts had fallen by
about 5.9%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Calithera Biosciences Inc shares had held steady so far
this
quarter and lost 39.3% so far this year.
    * Wall Street's median 12-month price target for Calithera
Biosciences Inc is $3.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated April 1 at 01:50 p.m.  ​All
figures in US dollars unless otherwise stated